Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
NCT ID: NCT06347133
Last Updated: 2025-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE3
1456 participants
INTERVENTIONAL
2024-05-21
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
NCT06347003
Study of Plozasiran in Adults With Severe Hypertriglyceridemia
NCT06347016
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
NCT06880770
PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease
NCT00455546
A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
NCT06816264
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Plozasiran Injection
4 doses of plozasiran by subcutaneous (sc) injection
Plozasiran Injection
ARO-APOC3 Injection
Placebo
calculated volume to match active treatment by sc injection
Placebo
sterile normal saline (0.9% NaCl)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Plozasiran Injection
ARO-APOC3 Injection
Placebo
sterile normal saline (0.9% NaCl)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Established diagnosis of hypertriglyceridemia (HTG) and prior documented evidence (medical history) of mean fasting TG level ≥150 mg/dL (≥1.69 mm/L) and ≤499 mg/dL (≤5.64 mmol/L)
* Mean fasting TG level ≥150 mg/dL (≥1.69 mmol/L) and ≤499 mg/dL (≤5.64 mmol/L) collected at 2 separate and consecutive visits at least 7 days apart and no more than 17 days apart during the screening period
* Fasting low density lipoprotein-cholesterol (LDL-C) ≤ 130 mg/dL (≤3.37 mmol/L) at screening
* Screening HbA1c ≤9.0%
* Willing to follow diet counseling and maintain a stable low-fat diet
* Must be on standard of care lipid and TG-lowering medications per local guidelines (unless documented as intolerant as determined by the Investigator, including an inability to safely administer or re-administer a specific drug because of fear, preference, genetic, clinical, or metabolic considerations, or due a previous adverse reaction associated with, attributed to, or caused by specific drug) prior to collection of qualifying TG levels.
Exclusion Criteria
* Use of any other hepatocyte targeted siRNA or antisense Oligonucleotide molecule within 60 days or within 5-half-lives before Day 1 based on plasma pharmacokinetics (PK), whichever is longer
* Acute pancreatitis within 4 weeks prior to screening
* Body mass index \>45 kg/m\^2
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arrowhead Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site 1
Birmingham, Alabama, United States
Research Site 2
Mobile, Alabama, United States
Research Site 3
Beverly Hills, California, United States
Research Site 4
Canoga Park, California, United States
Research Site 5
Garden Grove, California, United States
Research Site 6
Huntington Beach, California, United States
Research Site 7
Lake Forest, California, United States
Research Site 8
Lincoln, California, United States
Research Site 9
Long Beach, California, United States
Research Site 10
Montclair, California, United States
Research Site 11
Oxnard, California, United States
Research Site 12
Redding, California, United States
Research Site 13
Van Nuys, California, United States
Research Site 14
Colorado Springs, Colorado, United States
Research Site 15
Clearwater, Florida, United States
Research Site 16
Hialeah, Florida, United States
Research Site 17
Lake City, Florida, United States
Research Site 18
Miami Lakes, Florida, United States
Research Site 19
Mt. Dora, Florida, United States
Research Site 20
North Miami Beach, Florida, United States
Research Site 21
Orlando, Florida, United States
Research Site 22
Pensacola, Florida, United States
Research Site 23
Sarasota, Florida, United States
Research Site 24
Tamarac, Florida, United States
Research Site 25
Lawrenceville, Georgia, United States
Research Site 26
Macon, Georgia, United States
Research Site 27
Savannah, Georgia, United States
Research Site 28
Sugar Hill, Georgia, United States
Research Site 29
Park Ridge, Illinois, United States
Research Site 30
Elkhart, Indiana, United States
Research Site 31
Indianapolis, Indiana, United States
Research Site 32
South Bend, Indiana, United States
Research Site 33
Overland Park, Kansas, United States
Research Site 34
Topeka, Kansas, United States
Research Site 35
Louisville, Kentucky, United States
Research Site 36
Zachary, Louisiana, United States
Research Site 37
Annapolis, Maryland, United States
Research Site 38
Baltimore, Maryland, United States
Research Site 39
Flint, Michigan, United States
Research Site 40
Minneapolis, Minnesota, United States
Research Site 41
Olive Branch, Mississippi, United States
Research Site 42
Jefferson City, Missouri, United States
Research Site 43
St Louis, Missouri, United States
Research Site 44
Norfolk, Nebraska, United States
Research Site 46
Omaha, Nebraska, United States
Research Site 45
Omaha, Nebraska, United States
Research Site 47
Las Vegas, Nevada, United States
Research Site 48
Summit, New Jersey, United States
Research Site 52
New York, New York, United States
Research Site 51
New York, New York, United States
Research Site 53
Riverhead, New York, United States
Research Site 54
Rochester, New York, United States
Research Site 49
The Bronx, New York, United States
Research Site 50
The Bronx, New York, United States
Research Site 55
Vestal, New York, United States
Research Site 56
Asheboro, North Carolina, United States
Research Site 57
Morehead City, North Carolina, United States
Research Site 58
Wilmington, North Carolina, United States
Research Site 59
Winston-Salem, North Carolina, United States
Research Site 60
Beavercreek, Ohio, United States
Research Site 61
Cincinnati, Ohio, United States
Research Site 63
Columbus, Ohio, United States
Research Site 62
Columbus, Ohio, United States
Research Site 64
Norman, Oklahoma, United States
Research Site 66
Oklahoma City, Oklahoma, United States
Research Site 65
Oklahoma City, Oklahoma, United States
Research Site 67
Horsham, Pennsylvania, United States
Research Site 68
Newport, Pennsylvania, United States
Research Site 69
Newport, Pennsylvania, United States
Research Site 70
Philadelphia, Pennsylvania, United States
Research Site 71
Wilkes-Barre, Pennsylvania, United States
Research Site 72
Fort Mill, South Carolina, United States
Research Site 73
Greenville, South Carolina, United States
Research Site 74
Chattanooga, Tennessee, United States
Research Site 75
Powell, Tennessee, United States
Research Site 76
El Paso, Texas, United States
Research Site 77
Fort Worth, Texas, United States
Research Site 86
Houston, Texas, United States
Research Site 84
Houston, Texas, United States
Research Site 85
Houston, Texas, United States
Research Site 78
Houston, Texas, United States
Research Site 80
Houston, Texas, United States
Research Site 83
Houston, Texas, United States
Research Site 82
Houston, Texas, United States
Research Site 79
Houston, Texas, United States
Research Site 81
Houston, Texas, United States
Research Site 87
Laredo, Texas, United States
Research Site 88
Missouri City, Texas, United States
Research Site 89
Plano, Texas, United States
Research Site 90
San Antonio, Texas, United States
Research Site 91
Sugar Land, Texas, United States
Research Site 92
Tomball, Texas, United States
Research Site 93
Victoria, Texas, United States
Research Site 94
Bountiful, Utah, United States
Research Site 95
St. George, Utah, United States
Research Site 96
Manassas, Virginia, United States
Research Site 97
Seattle, Washington, United States
Research Site 102
CABA, Buenos Aires, Argentina
Research Site 100
CABA, Buenos Aires, Argentina
Research Site 103
Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina
Research Site 104
Córdoba, Córdoba Province, Argentina
Research Site 98
Córdoba, Córdoba Province, Argentina
Research Site 101
Godoy Cruz, Mendoza Province, Argentina
Research Site 105
Rosario, Santa Fe Province, Argentina
Research Site 99
Rosario, Santa Fe Province, Argentina
Research Site 106
Córdoba, , Argentina
Research Site 107
Blacktown, New South Wales, Australia
Research Site 108
Merewether, New South Wales, Australia
Research Site 110
Clayton, Victoria, Australia
Research Site 109
Heidelberg Heights, Victoria, Australia
Research Site 111
Blagoevgrad, , Bulgaria
Research Site 112
Burgas, , Bulgaria
Research Site 113
Byala, , Bulgaria
Research Site 114
Dimitrovgrad, , Bulgaria
Research Site 115
Haskovo, , Bulgaria
Research Site 116
Kyustendil, , Bulgaria
Research Site 117
Pleven, , Bulgaria
Research Site 118
Pleven, , Bulgaria
Research Site 120
Plovdiv, , Bulgaria
Research Site 119
Plovdiv, , Bulgaria
Research Site 121
Plovdiv, , Bulgaria
Research Site 122
Rousse, , Bulgaria
Research Site 123
Sevlievo, , Bulgaria
Research Site 137
Sofia, , Bulgaria
Research Site 133
Sofia, , Bulgaria
Research Site 126
Sofia, , Bulgaria
Research Site 129
Sofia, , Bulgaria
Research Site 132
Sofia, , Bulgaria
Research Site 130
Sofia, , Bulgaria
Research Site 131
Sofia, , Bulgaria
Research Site 135
Sofia, , Bulgaria
Research Site 124
Sofia, , Bulgaria
Research Site 125
Sofia, , Bulgaria
Research Site 127
Sofia, , Bulgaria
Research Site 134
Sofia, , Bulgaria
Research Site 128
Sofia, , Bulgaria
Research Site 136
Stara Zagora, , Bulgaria
Research Site 140
North Vancouver, British Columbia, Canada
Research Site 141
Victoria, British Columbia, Canada
Research Site 142
Brampton, Ontario, Canada
Research Site 143
Sarnia, Ontario, Canada
Research Site 144
Waterloo, Ontario, Canada
Research Site 145
Chicoutimi, Quebec, Canada
Research Site 146
Laval, Quebec, Canada
Research Site 149
Montreal, Quebec, Canada
Research Site 139
Québec, Quebec, Canada
Research Site 147
Québec, Quebec, Canada
Research Site 148
Québec, Quebec, Canada
Research Site 138
Halifax, , Canada
Research Site 151
Prague, Prague, Czechia
Research Site 157
Brno, , Czechia
Research Site 154
Hodonín, , Czechia
Research Site 159
Hradec Králové, , Czechia
Research Site 160
Náchod, , Czechia
Research Site 162
Olomouc, , Czechia
Research Site 155
Ostrava, , Czechia
Research Site 152
Prague, , Czechia
Research Site 156
Praha 4-Krc, , Czechia
Research Site 150
Slaný, , Czechia
Research Site 163
Teplice, , Czechia
Research Site 158
Trutnov, , Czechia
Research Site 161
Uherské Hradiště, , Czechia
Research Site 153
Ústí nad Labem, , Czechia
Research Site 164
Marseille, Bouches du Rhone, France
Research Site 167
Pessac, Gironde, France
Research Site 166
Lyon, Rhone, France
Research Site165
Paris, , France
Research Site 170
Deggingen, Baden-Wurttemberg, Germany
Research Site 169
Wallerfing, Bavaria, Germany
Research Site 168
Magdeburg, Saxony-Anhalt, Germany
Research Site 171
Békéscsaba, , Hungary
Research Site 175
Budapest, , Hungary
Research Site 183
Budapest, , Hungary
Research Site 179
Budapest, , Hungary
Research Site 184
Budapest, , Hungary
Research Site 180
Budapest, , Hungary
Research Site 182
Kaposvár, , Hungary
Research Site 176
Miskolc, , Hungary
Research Site 172
Pécs, , Hungary
Research Site 177
Pécs, , Hungary
Research Site 178
Szeged, , Hungary
Research Site 173
Veszprém, , Hungary
Research Site 174
Zalaegerszeg, , Hungary
Research Site 186
Rozzano, Milano, Italy
Research Site 187
Palermo, Sicily, Italy
Research Site 189
Bologna, , Italy
Research Site 185
Brescia, , Italy
Research Site 188
Milan, , Italy
Research Site 200
Bydgoszcz, , Poland
Research Site 202
Bydgoszcz, , Poland
Research Site 192
Elblag, , Poland
Research Site 193
Gdynia, , Poland
Research Site 190
Katowice, , Poland
Research Site 197
Krakow, , Poland
Research Site 204
Krakow, , Poland
Research Site 201
Lodz, , Poland
Research Site 191
Lodz, , Poland
Research Site 194
Malbork, , Poland
Research Site 199
Szczecin, , Poland
Research Site 207
Torun, , Poland
Research Site 205
Warsaw, , Poland
Research Site 198
Warsaw, , Poland
Research Site 196
Wroclaw, , Poland
Research Site 208
Wroclaw, , Poland
Research Site 206
Wroclaw, , Poland
Research Site 195
Zamość, , Poland
Research Site 203
Żarów, , Poland
Research Site 214
Banská Bystrica, , Slovakia
Research Site 212
Bardejov, , Slovakia
Research Site 217
Bratislava, , Slovakia
Research Site 216
Bratislava, , Slovakia
Research Site 210
Košice, , Slovakia
Research Site 213
Moldava nad Bodvou, , Slovakia
Research Site 209
Nové Zámky, , Slovakia
Research Site 211
Prešov, , Slovakia
Research Site 215
Rožňava, , Slovakia
Research Site 218
Žilina, , Slovakia
Research Site 221
Centurion, Gauteng, South Africa
Research Site 222
Krugersdorp, Gauteng, South Africa
Research Site 228
Pretoria, Gauteng, South Africa
Research Site 224
Durban, KwaZulu-Natal, South Africa
Research Site 227
Cape Town, Western Cape, South Africa
Research Site 219
Cape Town, Western Cape, South Africa
Research Site 223
Cape Town, Western Cape, South Africa
Research Site 225
Cape Town, Western Cape, South Africa
Research Site 220
Somerset West, Western Cape, South Africa
Research Site 226
Pretoria, , South Africa
Research Site 234
Barcelona, Barcelona, Spain
Research Site 229
A Coruña, La Coruña, Spain
Research Site 230
Barcelona, , Spain
Research Site 232
Madrid, , Spain
Research Site 231
Valencia, , Spain
Research Site 233
Zaragoza, , Spain
Research Site 236
Plymouth, Devon, United Kingdom
Research Site 235
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-509302-30
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
AROAPOC3-3009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.